|
GB1570494A
(en)
*
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
|
GB8912335D0
(en)
*
|
1989-05-30 |
1989-07-12 |
Smithkline Beckman Intercredit |
Compounds
|
|
US5280026A
(en)
*
|
1989-05-30 |
1994-01-18 |
Smithkline Beecham Intercredit B.V. |
Thienopyrimidines
|
|
US5098902A
(en)
*
|
1991-03-18 |
1992-03-24 |
Warner-Lambert Company |
Method of treating neurodegenerative diseases
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
US6608053B2
(en)
*
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
|
GB0423653D0
(en)
*
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
EA013108B1
(ru)
*
|
2006-04-19 |
2010-02-26 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Дигидротиенопиримидины для лечения воспалительных заболеваний
|
|
EP1847543A1
(de)
|
2006-04-19 |
2007-10-24 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
|
|
BRPI0710874A2
(pt)
*
|
2006-04-26 |
2012-02-14 |
Hoffmann La Roche |
compostos de tienopirimidina, processos de produção dos referidos compostos, composições farmacêuticas contendo os mesmos, kit, produto, e usos dos compostos
|
|
CN101511840A
(zh)
*
|
2006-04-26 |
2009-08-19 |
吉宁特有限公司 |
磷酸肌醇3-激酶抑制剂化合物及其使用方法
|
|
JP5546240B2
(ja)
|
2006-04-26 |
2014-07-09 |
ジェネンテック， インコーポレイテッド |
医薬化合物
|
|
RU2470936C2
(ru)
*
|
2006-12-07 |
2012-12-27 |
Дженентек, Инк. |
Соединения-ингибиторы фосфоинозитид 3-киназы и способы применения
|
|
US7888352B2
(en)
|
2006-12-07 |
2011-02-15 |
Piramed Limited |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
CA2704711C
(en)
|
2007-09-24 |
2016-07-05 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
|
JP5563466B2
(ja)
|
2007-10-19 |
2014-07-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規ピペラジノ−ジヒドロチエノピリミジン誘導体
|
|
KR20100075930A
(ko)
|
2007-10-19 |
2010-07-05 |
베링거 인겔하임 인터내셔날 게엠베하 |
헤테로사이클-치환된 피페라지노-디하이드로티에노피리미딘
|
|
CN104069112A
(zh)
*
|
2007-10-19 |
2014-10-01 |
贝林格尔.英格海姆国际有限公司 |
取代的哌啶子基-二氢噻吩并嘧啶
|
|
US8354528B2
(en)
|
2007-10-25 |
2013-01-15 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
EP2405916B1
(en)
|
2009-03-12 |
2018-02-07 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
|
|
US8158625B2
(en)
*
|
2009-05-27 |
2012-04-17 |
Genentech, Inc. |
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
|
|
KR20130026364A
(ko)
|
2009-05-27 |
2013-03-13 |
제넨테크, 인크. |
Ｐ110 델타에 대해 선택적인 비시클릭 피리미딘 ｐｉ3ｋ 억제제 화합물 및 사용 방법
|
|
PH12012500709A1
(en)
*
|
2009-10-12 |
2012-10-29 |
Hoffmann La Roche |
Combinations of a pi3k inhibitor and a mek inhibitor
|
|
CA2793892A1
(en)
|
2010-04-16 |
2011-10-20 |
Elizabeth Punnoose |
Foxo3a as predictive biomarker for pi3k/akt kinase pathway inhibitor efficacy
|
|
WO2012088254A1
(en)
|
2010-12-22 |
2012-06-28 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
|
US9802954B2
(en)
|
2011-08-24 |
2017-10-31 |
Boehringer Ingelheim International Gmbh |
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
|
|
US20130059866A1
(en)
|
2011-08-24 |
2013-03-07 |
Boehringer Ingelheim International Gmbh |
Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
|
|
MX369175B
(es)
|
2013-02-25 |
2019-10-30 |
Genentech Inc |
Métodos para detectar mutantes de akt resistentes a fármacos.
|
|
CN113423711B
(zh)
*
|
2018-10-01 |
2024-03-15 |
建新公司 |
作为udp糖基转移酶抑制剂的噻吩并[3,2-b]吡啶衍生物及其使用方法
|
|
GB202014736D0
(en)
*
|
2020-09-18 |
2020-11-04 |
Imperial College Innovations Ltd |
Novel compounds and their use in therapy
|